I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

John Sullivan Biography and Net Worth

Director of Mesa Laboratories

John Sullivan, Ph.D. was appointed as the Chairman of the Board upon his retirement from his position as Chief Executive Officer and President in September 2017. Dr. Sullivan was previously promoted to the position of Chief Executive Officer and President, in March 2009. Dr. Sullivan joined us in October 2004 in the role of Vice President of Sales and Marketing and was promoted to the positions of President and Chief Operating Officer in 2006. In 1988, Dr. Sullivan joined Varian, Inc. (a major analytical instrument manufacturer) and served in various capacities in Research and Development, Sales and Marketing Management, and Business Development until 2004. In 1982, Dr. Sullivan joined the U.S. Food and Drug Administration’s Seattle District Laboratory as a Senior Research Scientist and worked there until 1988. From 1976 until 1980, Dr. Sullivan was employed as an Analytical Chemist at BioMed Research Labs (an independent research and testing laboratory). Dr. Sullivan received his Bachelor of Science degree in Biology from Western Washington University in 1976 and a Ph.D. degree in Food Science from the University of Washington in 1982.

What is John James Sullivan's net worth?: The estimated net worth of John James Sullivan is at least $3.15 million as of June 7th, 2022. Dr. Sullivan owns 23,857 shares of Mesa Laboratories stock worth more than $3,151,033 as of December 22nd. This net worth estimate does not reflect any other assets that Dr. Sullivan may own. Learn More about John James Sullivan's net worth.
How do I contact John James Sullivan?: The corporate mailing address for Dr. Sullivan and other Mesa Laboratories executives is 12100 W 6TH AVE, LAKEWOOD CO, 80228. Mesa Laboratories can also be reached via phone at (303) 987-8000 and via email at [email protected]. Learn More on John James Sullivan's contact information.
Has John James Sullivan been buying or selling shares of Mesa Laboratories?: John James Sullivan has not been actively trading shares of Mesa Laboratories during the past quarter. Most recently, John James Sullivan sold 5,192 shares of the business's stock in a transaction on Tuesday, June 7th. The shares were sold at an average price of $207.76, for a transaction totalling $1,078,689.92. Following the completion of the sale, the director now directly owns 23,857 shares of the company's stock, valued at $4,956,530.32. Learn More on John James Sullivan's trading history.
Who are Mesa Laboratories' active insiders?: Mesa Laboratories' insider roster includes Brian Archbold (SVP), Gregory DiNoia (SVP), Evan Guillemin (Director), David Kelly (Director), Gary Owens (CEO), John Sakys (CFO), John Schmieder (Director), and John Sullivan (Director). Learn More on Mesa Laboratories' active insiders.
Are insiders buying or selling shares of Mesa Laboratories?: During the last twelve months, insiders at the medical instruments supplier sold shares 2 times. They sold a total of 4,017 shares worth more than $473,470.16. The most recent insider tranaction occured on October, 28th when CEO Gary M Owens sold 2,518 shares worth more than $286,095.16. Insiders at Mesa Laboratories own 4.4% of the company. Learn More about insider trades at Mesa Laboratories.
Information on this page was last updated on 10/28/2024.

John James Sullivan Insider Trading History at Mesa Laboratories

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/7/2022	Sell	5,192	$207.76	$1,078,689.92	23,857
2/15/2022	Sell	5,192	$259.42	$1,346,908.64
11/15/2021	Sell	5,192	$308.02	$1,599,239.84
10/1/2021	Sell	1,250	$304.48	$380,600.00
8/16/2021	Sell	5,192	$272.16	$1,413,054.72	28,549
8/2/2021	Sell	1,250	$290.47	$363,087.50
7/1/2021	Sell	1,250	$267.44	$334,300.00	24,299
6/8/2021	Sell	5,192	$258.19	$1,340,522.48	29,400
6/1/2021	Sell	2,215	$251.46	$556,983.90	24,208
5/6/2021	Sell	200	$250.05	$50,010.00	33,059
5/4/2021	Sell	735	$250.14	$183,852.90	33,159
4/5/2021	Sell	500	$250.76	$125,380.00	57,458
3/1/2021	Sell	1,250	$273.94	$342,425.00	57,958
2/1/2021	Sell	1,250	$277.67	$347,087.50	59,208
1/4/2021	Sell	1,250	$280.82	$351,025.00	60,458
12/1/2020	Sell	1,250	$275.22	$344,025.00	61,708
11/11/2020	Sell	1,250	$272.36	$340,450.00	62,481
2/27/2020	Sell	1,702	$256.02	$435,746.04	72,841
2/25/2020	Sell	8,206	$267.09	$2,191,740.54	77,347
6/15/2018	Sell	12,000	$197.02	$2,364,240.00	74,498
2/16/2018	Sell	4,000	$138.00	$552,000.00	72,248
2/21/2017	Sell	9,078	$124.83	$1,133,206.74	64,278
2/13/2017	Sell	5,922	$123.99	$734,268.78	68,040
6/22/2016	Sell	4,000	$121.63	$486,520.00	66,118
11/6/2015	Sell	2,400	$112.99	$271,176.00	61,393
2/25/2014	Sell	10,000	$87.01	$870,100.00
8/19/2013	Sell	6,000	$64.87	$389,220.00
8/14/2013	Sell	6,000	$61.92	$371,520.00

John James Sullivan Buying and Selling Activity at Mesa Laboratories

Mesa Laboratories Company Overview

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Today's Range

Now: $132.08

$129.75

$136.27

50 Day Range

MA: $120.47

$98.59

$135.91

2 Week Range

Now: $132.08

$83.68

$141.17

Volume

141,746 shs

Average Volume

41,646 shs

Market Capitalization

$717.19 million

P/E Ratio

N/A

Dividend Yield

0.50%

Beta

0.86

I was wrong. Dead wrong.

From Porter & Company | Ad